Vimarsana
Biggest News Aggregation in the World

Page 8 - Bgne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bgne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bgne Today - Breaking & Trending Today

Knights of Columbus Asset Advisors LLC Takes $77,000 Position in BeiGene, Ltd. (NASDAQ:BGNE) - Vimarsana News

Knights of Columbus Asset Advisors LLC Takes $77,000 Position in BeiGene, Ltd. (NASDAQ:BGNE)

Knights of Columbus Asset Advisors LLC bought a new stake in BeiGene, Ltd. (NASDAQ:BGNE – Free Report) in the first quarter, Holdings Channel reports. The institutional investor bought 357 shares of the company’s stock, valued at approximately $77,000. A number of other institutional investors and hedge funds have also made changes to their positions in […]

BeiGene Gets Positive CHMP Opinion for Tislelizumab to Treat Serious Esophageal Cancer - Vimarsana News

BeiGene Gets Positive CHMP Opinion for Tislelizumab to Treat Serious Esophageal Cancer

By Chris Wack BeiGene said Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion...

BeiGene, Ltd. (NASDAQ:BGNE) Shares Acquired by China Universal Asset Management Co. Ltd. - Vimarsana News

BeiGene, Ltd. (NASDAQ:BGNE) Shares Acquired by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. raised its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 18.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 577 shares of the company’s stock after purchasing an additional 91 shares […]

BeiGene: FDA to Review Brukinsa Combo in Relapsed, Refractory Follicular Lymphoma - Vimarsana News

BeiGene: FDA to Review Brukinsa Combo in Relapsed, Refractory Follicular Lymphoma

By Colin Kellaher BeiGene on Wednesday said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of Brukinsa for...

Julia Aijun Wang Sells 472 Shares of BeiGene, Ltd. (NASDAQ:BGNE) Stock - Vimarsana News

Julia Aijun Wang Sells 472 Shares of BeiGene, Ltd. (NASDAQ:BGNE) Stock

BeiGene, Ltd. (NASDAQ:BGNE – Free Report) CFO Julia Aijun Wang sold 472 shares of BeiGene stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $179.55, for a total value of $84,747.60. The transaction was disclosed in a document filed with the SEC, which is available at this […]